Consider Adjuvant Intensity Modulated Radiation Therapy to the Lymph Node Basin, Especially If the Melanoma Is BRAF Wild Type

International Journal of Radiation Oncology, Biology, Physics, Volume 98, Issue 1, 2017 May 1 | Foote, Matthew, BSc, MBBS (Hons), FRANZCR
This patient has operable stage III disease (1) , and the standard of care remains lymphadenectomy at this point in time. Although neoadjuvant therapy is attractive owing to the competing risks of regional and metastatic disease, this should only ...

http://ift.tt/2oDowuP